Royal Philips-Coordinated SHERPA Project Launches Seven Clinical Studies To Automate Brain Aneurysm And Liver Tumor Treatments Via EUR 21.5M EU-Co-Funded Research Program
فيليبس -1.58% Post
Koninklijke Philips N.V. Sponsored ADR PHG | 28.63 28.63 | -1.58% 0.00% Post |
- With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partners
- The project focuses on developing automated workflows for minimally invasive neurovascular and tumor treatments – clinical procedures where staffing levels and specialized expertise are in short supply
- The clinical studies are being conducted at University Medical Center Utrecht, St Antonius Hospital, University Medical Center Hamburg-Eppendorf, Hôpital Bicêtre AP-HP, and Hospital de la Santa Creu i Sant Pau
- On March 4 (16:30 - 17:30 CET), SHERPA will be featured at the European Congress of Radiology 2026 in a dedicated session